ESLAW

Estrella Immunopharma

0.0812

+0.0286+54.37%

Closed09:30 10/19 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.0812/0.0526

TODAY RANGE0.0812-0.0812

VOL500

MARKET CAP--

52 WEEK RANGE0.0500-0.2400

AVG VOL (3M)2.10K

% TURNOVER0%

TURNOVER--

P/E (TTM)-0.3202

% RANGE0.00%

EPS(TTM)-0.2536

P/E(FORWARD)--

P/B-0.4702

BVPS-0.1727

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP--

SHARES OUTSTANDING--

NEXT EARNINGS08/12-08/14

FREE FLOAT--

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·4d ago
Estrella Immunopharma doses first patient with EB103 in R/R NHL trial
TipRanks·10/01 16:30
Estrella’s EB103 Lymphoma Trial Advances, Keeping High-Risk Cell Therapy Hopes Alive
TipRanks·09/08 22:11
Estrella Immunopharma Faces Nasdaq Listing Compliance Challenge
NASDAQ·08/12 05:26
Estrella Adds Cleveland Site To STARLIGHT-1 Trial For B-cell Lymphoma; Stock Up
TipRanks·08/11 12:06
Estrella Immunopharma activates fourth clinical site for STARLIGHT-1 trial
TipRanks·08/03 12:05
Estrella Immunopharma activates third trial site for Starlight-1 trial
TipRanks·07/29 12:10
Estrella Immunopharma activates second clinical site for STARLIGHT-1 trial
TipRanks·07/24 12:05
Estrella announces first patient dosed in STARLIGHT-1 Phase I/II trial
TipRanks·06/30 21:54
Estrella Immunopharma Shareholders Ratify 2026 Auditor Appointment
Dow Jones·02/09 12:40
Estrella Immunopharma Is Maintained at Buy by D. Boral Capital
Dow Jones·02/09 12:40
Estrella Immunopharma Price Target Maintained With a $8.00/Share by D. Boral Capital
TipRanks·02/09 12:21
Estrella Immunopharma presents updated data on EB103
Dow Jones·01/28 12:14
Estrella Immunopharma Is Maintained at Buy by D. Boral Capital
Dow Jones·01/28 12:14
Estrella Immunopharma Price Target Cut to $8.00/Share From $16.00 by D. Boral Capital
TipRanks·01/13 22:48
Estrella Immunopharma Receives Nasdaq Non-Compliance Notice

Same Industry

Name/Symbol

Change%

Price

REGN

GridAI Tech

GRDX

-5.38%

4.220

BNTX

UTHR

Vertex Pharmaceuticals Inc

VRTX

-1.77%

499.74

SIGA

Moderna

MRNA

-7.82%

218.01

Charles Riv Labs Intl Inc

CRL

-1.99%

300.15

MEDP

Talphera Inc

TLPH

+0.93%

1.080

ICON plc

ICLR

-2.83%

170.18

CBPO

Iqvia Hldgs Inc

IQV

-1.53%

266.90

MOLN

Arcturus Therape

ARCT

-8.25%

10.34

GILD

PRAH

INCY

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.